Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-23 Sale | 2024-08-27 5:19 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,832 | $9.02 | $16,525 | 176,194 (Direct) | View |
| 2024-08-23 Sale | 2024-08-27 5:17 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 20,880 | $9.02 | $188,338 | 812,473 (Direct) | View |
| 2024-05-23 Sale | 2024-05-28 5:01 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 2,274 | $5.84 | $13,280 | 178,026 (Direct) | View |
| 2024-05-23 Sale | 2024-05-28 5:00 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 21,626 | $5.79 | $125,215 | 833,353 (Direct) | View |
| 2024-02-26 Purchase | 2024-02-27 4:43 pm | OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner | 930,851 | $7.52 | $7,000,000 | 8,591,401 (Indirect) | View |
| 2024-02-05 Sale | 2024-02-06 6:38 pm | OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer | 5,910 | $4.86 | $28,723 | 243,689 (Direct) | View |
| 2024-02-05 Sale | 2024-02-06 6:35 pm | OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel | 6,029 | $4.86 | $29,301 | 336,493 (Direct) | View |
| 2024-02-05 Sale | 2024-02-06 6:32 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 6,346 | $4.86 | $30,842 | 353,054 (Direct) | View |
| 2024-02-05 Sale | 2024-02-06 6:29 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 6,212 | $4.86 | $30,190 | 380,356 (Direct) | View |
| 2024-02-05 Sale | 2024-02-06 6:26 pm | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 19,642 | $4.86 | $95,460 | 1,144,601 (Indirect Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:03 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 6,433 | $4.95 | $31,843 | 139,932 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:02 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 7,764 | $4.95 | $38,432 | 92,767 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:01 pm | OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel | 6,831 | $4.95 | $33,813 | 109,218 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:01 pm | OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer | 5,147 | $4.95 | $25,478 | 89,619 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:00 pm | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 18,338 | $4.95 | $90,773 | 434,443 (Indirect Direct) | View |
| 2023-12-14 Purchase | 2023-12-18 4:52 pm | OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner | 1,538,461 | $3.25 | $4,999,998 | 7,660,550 (Indirect) | View |
| 2023-08-30 Purchase | 2023-09-05 08:27 am | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 6,500 | $3.81 | $24,765 | 452,781 (Indirect Direct) | View |
| 2023-07-07 Sale | 2023-07-11 8:00 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 832 | $4.93 | $4,102 | 100,531 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-07 Option Award | 2024-10-09 5:32 pm | N/A 2034-10-06 | OCULAR THERAPEUTIX INC | OCUL | Anderman Todd Chief Legal Officer | 395,200 | $0 | 395,200 (Direct) | View |
| 2024-10-02 Option Award | 2024-10-04 5:21 pm | N/A 2034-10-01 | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 300,000 | $0 | 415,984 (Direct) | View |
| 2024-10-02 Option Award | 2024-10-04 5:20 pm | N/A 2034-10-01 | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 300,000 | $0 | 472,007 (Direct) | View |
Ownership | 2024-10-04 5:18 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 0 | $0 | 682,650 (Direct) | View |
Ownership | 2024-10-04 5:17 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 0 | $0 | 745,186 (Direct) | View |
| 2024-08-29 Option Award | 2024-09-03 4:08 pm | N/A 2034-08-28 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 44,636 | $0 | 242,590 (Direct) | View |
| 2024-02-27 Exercise | 2024-07-26 7:30 pm | N/A 2024-04-13 | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 30,302 | $0 | 198,704 (Direct) | View |
| 2024-02-27 Exercise | 2024-07-26 7:30 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 30,302 | $8.8 | 198,704 (Direct) | View |
| 2024-07-24 Option Award | 2024-07-26 7:30 pm | N/A 2034-07-23 | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 48,000 | $0 | 198,704 (Direct) | View |
| 2024-07-24 Option Award | 2024-07-26 6:41 pm | N/A 2034-07-23 | OCULAR THERAPEUTIX INC | OCUL | Hong Seung Suh Director | 48,000 | $0 | 68,933 (Direct) | View |
| 2024-07-24 Option Award | 2024-07-26 6:40 pm | N/A 2034-07-23 | OCULAR THERAPEUTIX INC | OCUL | RAINES MERILEE Director | 48,000 | $0 | 68,933 (Direct) | View |
| 2024-07-24 Option Award | 2024-07-26 6:40 pm | N/A 2034-07-23 | OCULAR THERAPEUTIX INC | OCUL | Williams Leslie J. Director | 48,000 | $0 | 73,433 (Direct) | View |
| 2024-07-24 Option Award | 2024-07-26 6:39 pm | N/A 2034-07-23 | OCULAR THERAPEUTIX INC | OCUL | Warden Charles M Director | 48,000 | $0 | 108,464 (Direct) | View |
| 2024-07-24 Option Award | 2024-07-26 6:38 pm | N/A 2034-07-23 | OCULAR THERAPEUTIX INC | OCUL | Graves Adrienne L Director | 48,000 | $0 | 72,000 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-04 5:28 pm | N/A 2034-05-31 | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 566,666 | $0 | 566,666 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 8:07 pm | N/A 2024-02-21 | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin Executive Chairman | 2,137,448 | $0 | 2,137,448 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 8:06 pm | N/A 2024-02-21 | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 324,850 | $0 | 424,850 (Direct) | View |
Ownership | 2024-02-26 8:02 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 0 | $0 | 100,000 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:38 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer | 159,980 | $0 | 243,689 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:35 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel | 233,304 | $0 | 336,493 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:32 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 266,633 | $0 | 353,054 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:29 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 246,636 | $0 | 380,356 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:26 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 729,800 | $0 | 1,144,601 (Direct) | View |
| 2023-08-02 Option Award | 2023-08-18 8:45 pm | N/A 2033-08-01 | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Director | 17,350 | $0 | 17,350 (Direct) | View |
| 2023-07-10 Option Award | 2023-07-12 5:18 pm | N/A 2033-07-09 | OCULAR THERAPEUTIX INC | OCUL | Graves Adrienne L Director | 96,000 | $0 | 96,000 (Direct) | View |